Why antimicrobial resistance is accelerating and how science is responding
Antimicrobial resistance (AMR) is steadily eroding our ability to treat infections and the pace of change is accelerating.
Across homes, farms and healthcare systems, the misuse of antibiotics, combined with gaps in understanding and fragile infrastructures, is deepening a global resistance crisis. The consequences are already being felt by patients and healthcare professionals alike and the challenge continues to grow.
To explore what is driving antimicrobial resistance and where science is making progress, Nature has released a new interactive Nature Outlook on antimicrobial resistance, bringing together in‑depth journalism, expert insight and multimedia storytelling on one of medicine’s most urgent challenges.
The Outlook is produced with financial support from Meiji Seika Pharma, while maintaining Nature’s editorial independence. It examines how antibiotic overuse persists across different settings, including the role of informal access, private care and how social, economic and regulatory factors can shape day‑to‑day decisions around antimicrobial use.
Explore the features:
- Feature 1: Street sellers and private physicians fuel antibiotic overuse – this feature examines how informal access and private care can amplify overuse and what that means for resistance.
- Feature 2: Old antibiotics are being revived to fight new threats – explore why “old” doesn’t necessarily mean obsolete in the fight against resistance.
- Partner feature: New science for old enemies: Tackling multidrug-resistant infections – discover the new strategies being developed to confront resistant infections and what’s needed to translate progress into real‑world impact.
- Video: The hunt for the next antibiotics – watch the scientific & practical obstacles and where new momentum may be emerging
Together, these pieces highlight the breadth of the response from revisiting established drugs to developing new therapeutic approaches designed to outpace evolving resistance mechanisms. Advances in diagnostics, drug discovery and microbiology are opening new avenues, even as economic and regulatory hurdles remain.
Interested in supporting high‑trust, editorially independent science communication on urgent global challenges? We offer you a range of Supported Content options designed to help you engage researchers, clinicians and decision‑makers in a credible environment.
Learn more about Supported Content or contact our team.
About Nature Outlooks:
Nature Outlooks are editorially independent supplements in Nature, written by leading science journalists and focused on key research topics.
Each Outlook is funded by a partner organization, offering sponsors a credible way to showcase their role in advancing the field and highlight emerging opportunities to a global audience of researchers and policy‑makers.
Brand partners benefit from Nature’s trusted editorial environment, wide reach, and the ability to link their scientific or healthcare innovations with readers seeking authoritative insights. The format — combining journalism, multimedia, and curated research – enhances visibility, user experience, and engagement.
Explore tailored partnership options through our Supported Content program.
